CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Lumen Bioscience, Inc.

For profitWebsite ↗

Also known as: Lumen Bioscience, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 18, 2024

Timeline

2010s

Jan 1, 2017
Lumen Bioscience, Inc.— Founded

Drugs by trial phase (4 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

spirulina

Phase 2 (1 own, 0 via acquisition)

lmn-101

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Campylobacter Infections

Recent trials (6)

NCT06556940Lead sponsorEarly Phase 1Sep 18, 2024
NCT06030414Lead sponsorPhase 1Oct 6, 2023
NCT05330182Lead sponsorPhase 2/Phase 3Apr 1, 2023
NCT04893239Lead sponsorPhase 1Aug 18, 2021
NCT04182490Lead sponsorPhase 2Feb 29, 2020
NCT04098263Lead sponsorPhase 1Jan 31, 2020

Details

Founded: Seattle, WA, US Jan 1, 2017
Last known activity: Sep 18, 2024